Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?

• Dave Singh,
• Gerard J. Criner,
• Ian Naya,
• Paul W. Jones,
• Lee Tombs,
• David A. Lipson,
• MeiLan K. Han

Affiliations

Dave Singh

Medicines Evaluation Unit, Manchester University NHS Foundation Trust, University of Manchester

Gerard J. Criner

Lewis Katz School of Medicine, Temple University

Ian Naya

GSK, Respiratory Medicines Development Centre

Paul W. Jones

GSK, Respiratory Medicines Development Centre

Lee Tombs

Precise Approach Ltd

David A. Lipson

GSK, Respiratory Clinical Sciences

MeiLan K. Han

Division of Pulmonary and Critical Care, University of Michigan Health System